Aimei Health Technology saw its shares tumble over 30% in extended trading after announcing the immediate termination of its business combination agreement with United Hydrogen Group. The blank-check company delivered the termination notice on July 7, after the two entities failed to consummate the merger by the agreed-upon outside deadline. CEO Xie Junheng stated that while the proposed business combination could not be completed within the required timeframe, the company remains confident in its ability to identify and execute a compelling transaction in the future.
Aimei Health Technology Co., Ltd Ordinary ShareTermination of merger deal with United Hydrogen Group, causing stock to drop 30%.